Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Lab Invest. 2011 Apr;91(4):609-18. doi: 10.1038/labinvest.2011.2. Epub 2011 Feb 14.
Our previous study revealed that blockade of interleukin-6 (IL-6)-STAT3 signaling ameliorated liver injury, although hepatic STAT3(-/-) or GP130(-/-) mice have been reported to develop severe liver injury, in a murine methionine choline deficient (MCD) diet-induced model of non-alcoholic steatohepatitis (NASH). In this study, to determine whether profound blockade of IL-6-STAT3 signaling may still ameliorate liver injury, we studied db/db mice, which have impaired leptin-mediated STAT3 activation, using the MCD diet-induced NASH model. Male lean and db/db mice (6 weeks old) were fed either control chow or an MCD diet for 8 or 12 weeks. Half of the mice were treated with 15 mg/kg rat anti-mouse IL-6 receptor neutralizing antibody (MR16-1) intraperitoneally twice weekly, the remainder were injected with 15 mg/kg rat IgG as a control. Hepatic steatosis, injury, fibrosis, markers of lipid peroxidation/oxidant stress and antiapoptotic gene expression were evaluated. Plasma IL-6 levels were elevated in all groups of db/db mice. Although hepatic IL-6/ GP130 signaling was activated in chow-fed db/db mice, this was suppressed in MCD diet-fed db/db mice, accompanied by downregulation of hepatic IL-6 receptor and GP130 mRNA expression. MR16-1 treatment of MCD diet-fed db/db mice further repressed STAT3 activities and expression of STAT3-related antiapoptotic genes, such as Bcl-2 and Ref-1, but increased plasma-free fatty acid and hepatic markers of lipid peroxidation/oxidant stress, leading to increased liver injury, hepatocyte apoptosis and liver fibrosis. Although 'moderate' blockade of enhanced IL-6-STAT3 signaling may be beneficial in NASH, as we reported previously, these findings demonstrate that a profound defect in STAT3 activation is detrimental in terms of liver injury, hepatocyte apoptosis and liver fibrosis, indicating the hepato-protective role of IL-6 signaling in this severe NASH model.
我们之前的研究表明,阻断白细胞介素-6 (IL-6)-STAT3 信号通路可以改善肝损伤,尽管已经有报道称肝 STAT3(-/-) 或 GP130(-/-) 小鼠在非酒精性脂肪性肝炎 (NASH) 的蛋氨酸胆碱缺乏 (MCD) 饮食诱导模型中会发展为严重的肝损伤。在这项研究中,为了确定是否深度阻断 IL-6-STAT3 信号通路仍能改善肝损伤,我们使用 MCD 饮食诱导的 NASH 模型研究了瘦素介导的 STAT3 激活受损的 db/db 小鼠。雄性 lean 和 db/db 小鼠 (6 周龄) 分别用对照饲料或 MCD 饮食喂养 8 或 12 周。一半的小鼠每周两次腹膜内注射 15mg/kg 抗鼠 IL-6 受体中和抗体 (MR16-1),另一半注射 15mg/kg 大鼠 IgG 作为对照。评估肝脂肪变性、损伤、纤维化、脂质过氧化/氧化应激标志物和抗凋亡基因表达。所有 db/db 小鼠的血浆 IL-6 水平均升高。尽管在 chow 喂养的 db/db 小鼠中激活了肝 IL-6/GP130 信号,但在 MCD 饮食喂养的 db/db 小鼠中被抑制,同时肝 IL-6 受体和 GP130 mRNA 表达下调。MR16-1 治疗 MCD 饮食喂养的 db/db 小鼠进一步抑制了 STAT3 活性和 STAT3 相关抗凋亡基因的表达,如 Bcl-2 和 Ref-1,但增加了血浆游离脂肪酸和肝脂质过氧化/氧化应激标志物,导致肝损伤、肝细胞凋亡和肝纤维化增加。尽管我们之前报道过,“适度”阻断增强的 IL-6-STAT3 信号可能对 NASH 有益,但这些发现表明 STAT3 激活的严重缺陷对肝损伤、肝细胞凋亡和肝纤维化是有害的,表明 IL-6 信号在这种严重的 NASH 模型中具有肝保护作用。